You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

POTASSIUM Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Potassium, and when can generic versions of Potassium launch?

Potassium is a drug marketed by Exela Pharma, Hospira, Hexcel, Actavis Labs Fl Inc, Adare Pharms Inc, Amneal Pharms, Chartwell Molecular, Endo Operations, Glenmark Pharms Ltd, Granules, Lupin Ltd, Nesher Pharms, Novel Labs Inc, Padagis Us, Prinston Inc, Strides Pharma, Teva, Tris Pharma Inc, Zydus Pharms, Amneal, Belcher, Epic Pharma Llc, Genus, Novitium Pharma, Rubicon, Abraxis Pharm, B Braun, Baxter Hlthcare, Fresenius Kabi Usa, Gd Searle Llc, Intl Medication, Lilly, Luitpold, Miles, Nexus Pharms, Pharma Serve Ny, Watson Labs, Anda Repository, Apotex, Genus Lifesciences, Pharm Assoc, Sciegen Pharms Inc, Wes Pharma Inc, Ascent Pharms Inc, Aurobindo Pharma, Aurobindo Pharma Ltd, Breckenridge, Chartwell Rx, Copley Pharm, Guangzhou Novaken, Macleods Pharms Ltd, Mylan, Rising, Schering, Sigmapharm Labs Llc, Twi Pharms, Yichang Humanwell, Icu Medical Inc, Nexus, Ut Sw Medctr, Ani Pharms, Bionpharma, Hibrow Hlthcare, Teva Pharms Usa Inc, Torrent, Mission Pharmacal, Roxane, Am Regent, Cmp Dev Llc, and Somerset Theraps Llc. and is included in one hundred and fifty-two NDAs. There is one patent protecting this drug.

The generic ingredient in POTASSIUM is potassium phosphate, dibasic; potassium phosphate, monobasic. There are two hundred and forty drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the potassium phosphate, dibasic; potassium phosphate, monobasic profile page.

DrugPatentWatch^® Generic Entry Outlook for Potassium

Annual sales in 2021 were $9mm indicating the motivation for generic entry (peak sales were $76mm in 2019).

Indicators of Generic Entry

< Available with Subscription >

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for POTASSIUM?
What are the global sales for POTASSIUM?
What is Average Wholesale Price for POTASSIUM?

Summary for POTASSIUM

US Patents:	0
Applicants:	70
NDAs:	152
Drug Prices:	Drug price information for POTASSIUM
Drug Sales Revenues:	Drug sales revenues for POTASSIUM
DailyMed Link:	POTASSIUM at DailyMed

Drug patent expirations by year for POTASSIUM

Drug Prices for POTASSIUM

US Patents and Regulatory Information for POTASSIUM

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ut Sw Medctr	POTASSIUM CITRATE	potassium citrate	FOR SOLUTION;ORAL	019647-002	Oct 13, 1988		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Luitpold	POTASSIUM CHLORIDE	potassium chloride	INJECTABLE;INJECTION	080221-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Fresenius Kabi Usa	POTASSIUM CHLORIDE 20MEQ	potassium chloride	INJECTABLE;INJECTION	211087-005	May 7, 2021	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
B Braun	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	dextrose; potassium chloride; sodium chloride	INJECTABLE;INJECTION	019630-035	Feb 17, 1988		RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Pharm Assoc	POTASSIUM CHLORIDE	potassium chloride	SOLUTION;ORAL	210766-001	Mar 29, 2019	AA	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Baxter Hlthcare	POTASSIUM CHLORIDE 0.3% AND SODIUM CHLORIDE 0.9%	potassium chloride; sodium chloride	INJECTABLE;INJECTION	017648-002	Approved Prior to Jan 1, 1982	AP	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Novitium Pharma	POTASSIUM CHLORIDE	potassium chloride	FOR SOLUTION;ORAL	212816-001	Jul 12, 2023	AA	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.